T. Oligino

发表

Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model

J. Contreras, D. Curiel, J. Thomas, 2000, Gene Therapy.

Herpes Simplex Virus Vector-Mediated Expression of Bcl-2 Protects Spinal Motor Neurons from Degeneration Following Root Avulsion

J. Glorioso, D. Fink, J. Goss, 2001, Experimental Neurology.

Effect of temperature, medium composition, and cell passage on production of herpes-based viral vectors.

M. Ataai, J. Glorioso, A. Ozuer, 2002, Biotechnology and bioengineering.

Bcl-2 and GDNF Delivered by HSV-Mediated Gene Transfer Act Additively to Protect Dopaminergic Neurons from 6-OHDA-Induced Degeneration

J. Glorioso, D. Fink, J. Goss, 2001, Experimental Neurology.

Development of an HSV-Based Vector for the Treatment of Parkinson's Disease

J. Glorioso, W. Goins, D. Fink, 1997, Experimental Neurology.

Engineering Herpes Simplex

R. Ramakrishnan, Martin C. Schmidt, J. Glorioso, 1997 .

Implications of maturation for viral gene delivery to skeletal muscle

J. Glorioso, J. Huard, P. Marconi, 1998, Neuromuscular Disorders.

Gene transfer to muscle using herpes simplex virus-based vectors

Simon C Watkins, J. Glorioso, J. Huard, 1997, Neuromuscular Disorders.

Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.

S. Moriuchi, J. Cohen, D. Krisky, 1998, Cancer research.

High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector.

D. Curiel, C. Rancourt, M. Wang, 1998, Gynecologic oncology.

Rapid method for construction of recombinant HSV gene transfer vectors

R. Rouse, J. Glorioso, P. Marconi, 1997, Gene Therapy.

Replication-defective herpes simplex virus vectors for gene transfer in vivo.

R. Ramakrishnan, P. L. Poliani, J. Glorioso, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Engineering herpes simplex virus vectors for human gene therapy.

R. Ramakrishnan, J. Glorioso, W. Goins, 1997, Advances in pharmacology.

Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.

T. Curiel, K. Kasono, J. Xiang, 1998, Biochemical and biophysical research communications.

Future of adenoviruses in the gene therapy of arthritis

P. Robbins, C. Evans, S. Ghivizzani, 2001, Arthritis research.

Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect.

J. Glorioso, D. Fink, J. Goss, 2002, Journal of neurotrauma.

Herpes simplex virus vectors for gene transfer to the nervous system.

R. Ramakrishnan, J. Glorioso, W. Goins, 1997, Journal of neurovirology.

Gene transfer to muscle and spinal cord using herpes simplex virus-based vectors.

J. Glorioso, J. Huard, W. Goins, 2002 .

8 Gene-transfer Tool: Herpes Simplex Virus Vectors

J. Glorioso, W. Goins, D. Fink, 1999 .

In vivo transgene activation from an HSV-based gene therapy vector by GAL4:vp16.

M. Schmidt, J. Glorioso, P. Marconi, 1996, Gene therapy.

Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo.

J. Glorioso, J. Goss, M. Mata, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Drug inducible transgene expression in brain using a herpes simplex virus vector

J. Glorioso, T. Oligino, J. Glorioso, 1998, Gene Therapy.